Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

NCR graphs - Incidence rates by year

- All cancer including non-melanoma skin cancer, crude incidence rate, males, 2005-2015
- All cancer including non-melanoma skin cancer, crude incidence rate, females, 2005-2015

- All cancer excluding non-melanoma skin cancer, crude incidence rate, males, 2005-2015
- All cancer excluding non-melanoma skin cancer, crude incidence rate, females, 2005-2015

- Oesophagus cancer, crude incidence rate, males, 2005-2015
- Oesophagus cancer, crude incidence rate, females, 2005-2015

- Stomach cancer, crude incidence rate, males, 2005-2015
- Stomach cancer, crude incidence rate, females, 2005-2015

- Colo-rectal cancer, crude incidence rate, males, 2005-2015
- Colo-rectal cancer, crude incidence rate, females, 2005-2015

- Liver cancer, crude incidence rate, males, 2005-2015
- Liver cancer, crude incidence rate, females, 2005-2015

- Gallbladder and extrahepatic bilary tract cancer, crude incidence rate, males, 2005-2015
- Gallbladder and extrahepatic bilary tract cancer, crude incidence rate, females, 2005-2015

- Pancreas cancer, crude incidence rate, males, 2005-2015
- Pancreas cancer, crude incidence rate, females, 2005-2015

- Larynx cancer, crude incidence rate, males, 2005-2015
- Larynx cancer, crude incidence rate, females, 2005-2015

- Trachea-bronchus-lung cancer, crude incidence rate, males, 2005-2015
- Trachea-bronchus-lung cancer, crude incidence rate, females, 2005-2015

- Bone cancer, crude incidence rate, males, 2005-2015
- Bone cancer, crude incidence rate, females, 2005-2015

- Melanoma, crude incidence rate, males, 2005-2015
- Melanoma, crude incidence rate, females, 2005-2015

- Non-melanoma skin cancer, crude incidence rate, males, 2005-2015
- Non-melanoma skin cancer, crude incidence rate, females, 2005-2015

- Mesothelioma, crude incidence rate, males, 2005-2015
- Mesothelioma, crude incidence rate, females, 2005-2015

- Breast cancer, crude incidence rate, males, 2005-2015
- Breast cancer, crude incidence rate, females, 2005-2015

- Col uteri cancer, crude incidence rate, females, 2005-2015
- Corpus uteri cancer, crude incidence rate, females, 2005-2015
- Ovary cancer, crude incidence rate, females, 2005-2015

- Prostate cancer, crude incidence rate, males, 2005-2015
- Testis cancer, crude incidence rate, males, 2005-2015

- Kidney cancer, crude incidence rate, males, 2005-2015
- Kidney cancer, crude incidence rate, females, 2005-2015

- Bladder cancer, crude incidence rate, males, 2005-2015
- Bladder cancer, crude incidence rate, females, 2005-2015

- Brain and central nervous system cancer, crude incidence rate, males, 2005-2015
- Brain and central nervous system cancer, crude incidence rate, females, 2005-2015

- Thyroid cancer, crude incidence rate, males, 2005-2015
- Thyroid cancer, crude incidence rate, females, 2005-2015

- Hodgkin's lymphoma, crude incidence rate, males, 2005-2015
- Hodgkin's lymphoma, crude incidence rate, females, 2005-2015

- Non-Hodgkin lymphoma, crude incidence rate, males, 2005-2015
- Non-Hodgkin lymphoma, crude incidence rate, females, 2005-2015

- Lymphoma all types, crude incidence rate, males, 2005-2015
- Lymphoma all types, crude incidence rate, females, 2005-2015

- Multiple myeloma, crude incidence rate, males, 2005-2015
- Multiple myeloma, crude incidence rate, females, 2005-2015

- Lymphoid leukemia, crude incidence rate, males, 2005-2015
- Lymphoid leukemia, crude incidence rate, females, 2005-2015

- Myeloid leukemia, crude incidence rate, males, 2005-2015
- Myeloid leukemia, crude incidence rate, females, 2005-2015

- Leukemia all types, crude incidence rate, males, 2005-2015
- Leukemia all types, crude incidence rate, females, 2005-2015

 
    ...
    116
    ...
ATC Name B/G Ingredients Dosage Form Price
C10AA08 PIVAL G Pitavastatin - 4mg 4mg Tablet 1,265,772 L.L
N05AH03 OLANZAMED G Olanzapine - 5mg 5mg Tablet 665,522 L.L
N05AH03 OLANZAPINE ARROW G Olanzapine - 5mg 5mg Tablet 670,577 L.L
N06BA07 MODAFINIL ARROW G Modafinil - 100mg 100mg Tablet 5,361,932 L.L
C09DA01 HYZAAR B Losartan potassium - 100mg, Hydrochlorothiazide - 12.5mg Tablet 1,740,596 L.L
C09DA01 LOSANET-H FORTE G Losartan potassium - 100mg, Hydrochlorothiazide - 12.5mg Tablet 395,474 L.L
C10AB05 FENOFIBRATE ARROW G Fenofibrate - 160mg 160mg Tablet 639,669 L.L
L02BX03 ABLAX 250 G Abiraterone acetate - 250mg 250mg Tablet L.L
C07AB03 APO-ATENOL G Atenolol - 50mg 50mg Tablet 327,898 L.L
C10AB05 LIPAFIB G Fenofibrate - 160mg 160mg Tablet 627,127 L.L
B03BB01 ACFOL G Folic acid - 5mg 5mg Tablet 355,798 L.L
C07AB03 ATONIUM G Atenolol - 50mg 50mg Tablet 239,588 L.L
B03BB01 FOLICIL G Folic acid - 5mg 5mg Tablet 584,571 L.L
C07AB03 BLOKIUM 50MG G Atenolol - 50mg 50mg Tablet 186,794 L.L
C09DA03 ARBITEN PLUS G Valsartan - 160mg, Hydrochlorothiazide - 12.5mg Tablet 544,256 L.L
C07AB03 ATONIUM G Atenolol - 100mg 100mg Tablet 461,207 L.L
L01BB02 PURI-NETHOL B Mercaptopurine - 50mg 50mg Tablet 830,495 L.L
N05AH03 OLANZAMED G Olanzapine - 20mg 20mg Tablet 3,941,938 L.L
C07AB03 BLOKIUM 100MG G Atenolol - 100mg 100mg Tablet 377,620 L.L
J01XE01 NITROFURANTOIN G Nitrofurantoin - 100mg 100mg Tablet 972,942 L.L
C10AX09 EZETROL B Ezetimibe - 10mg 10mg Tablet 3,680,849 L.L
A11DB 3V G Vitamin B12 - 200mcg, Vitamin B6 - 200mg, Vitamin B1 - 100mg Tablet 229,797 L.L
C10AX09 EZETIMIBE BIOGARAN G Ezetimibe - 10mg 10mg Tablet 1,894,818 L.L
L01BB04 MAVENCLAD B Cladribine - 10mg 10mg Tablet 192,617,092 L.L
C10AX09 EZETRALEX G Ezetimibe - 10mg 10mg Tablet 972,686 L.L
N02BE01 PARANOR G Paracetamol - 650mg 650mg Tablet 162,605 L.L
C09DA03 ARBITEN PLUS G Valsartan - 160mg, Hydrochlorothiazide - 25mg Tablet 579,196 L.L
C10AX09 XIMACOL G Ezetimibe - 10mg 10mg Tablet 1,894,818 L.L
C07AB07 APO-BISOPROLOL G Bisoprolol fumarate - 5mg 5mg Tablet 923,220 L.L
C10AX09 ZEMIL G Ezetimibe - 10mg 10mg Tablet 944,529 L.L
    ...
    116
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025